Skip to main content
OpenTrials

Clinical trial condition

Nonalcoholic Steatohepatitis (NASH)

Explore clinical trials studying Nonalcoholic Steatohepatitis (NASH). Study availability and eligibility vary by location and protocol.

33 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Nonalcoholic Steatohepatitis (NASH) trial results

Completed

Study of NGM282 in Patients With Nonalcoholic Steatohepatitis (NASH)

NCT02443116

Conditions
Digestive System Diseases, Fatty Liver, Liver Diseases, +2 more
Locations
  • NGM Clinical Study Site 922 Chandler, Arizona, United States
  • NGM Clinical Study Site 923 Tucson, Arizona, United States
  • NGM Clinical Study Site 924 Los Angeles, California, United States
  • NGM Clinical Study Site 901 San Diego, California, United States
View all 22 locations
View Trial Details
Completed

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Patients With Presumed Nonalcoholic Steatohepatitis (NASH)

NCT05117489

Conditions
Digestive System Diseases, Fatty Liver, Liver Diseases, +2 more
Locations
  • Site 207 Chandler, Arizona, United States
  • Site 209 Tucson, Arizona, United States
  • Site 214 Panorama City, California, United States
  • Site 233 Santa Ana, California, United States
View Trial Details
Completed

A Sub Study of the Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Patients With Presumed Nonalcoholic Steatohepatitis (NASH)

NCT05320146

Conditions
Digestive System Diseases, Fatty Liver, Liver Diseases, +2 more
Locations
  • Site 207 Chandler, Arizona, United States
  • Site 209 Tucson, Arizona, United States
  • Site 214 Panorama City, California, United States
  • Site 233 Santa Ana, California, United States
View Trial Details
Completed

The Efficacy, Safety and Tolerability of Oral LPCN 1144 in Subjects With Nonalcoholic Steatohepatitis

NCT04134091

Conditions
Digestive System Diseases, Fatty Liver, Liver Diseases, +2 more
Locations
  • TriWest Research Associates, LLC El Cajon, California, United States
  • United Medical Doctors Murrieta, California, United States
  • Inland Empire Liver Foundation Rialto, California, United States
  • Clinical Trials Research Roseville, California, United States
View all 19 locations
View Trial Details
Completed

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of CS0159 in Subjects With NASH

NCT05591079

Conditions
Digestive System Diseases, Fatty Liver, Liver Diseases, +2 more
Locations
  • National Research Institute - Gardena Gardena, California, United States
  • Velocity Clinical Research, Huntington Park Huntington Park, California, United States
  • Velocity Clinical Research - Panorama City Panorama City, California, United States
  • Velocity Clinical Research - Santa Ana Santa Ana, California, United States
View all 17 locations
View Trial Details
Completed

Leronlimab (PRO 140) in Patients With Nonalcoholic Steatohepatitis

NCT04521114

Conditions
Digestive System Diseases, Fatty Liver, Liver Diseases, +2 more
Locations
  • Southern California Research Center Coronado, California, United States
  • Meridien Research Maitland, Florida, United States
  • Floridian Clinical Research Miami Lakes, Florida, United States
  • Sensible Healthcare, LLC Ocoee, Florida, United States
View Trial Details
Completed

Safety, Tolerability, and Efficacy of Selonsertib, Firsocostat, and Cilofexor in Adults With Nonalcoholic Steatohepatitis (NASH)

NCT02781584

Conditions
Digestive System Diseases, Fatty Liver, Liver Diseases, +3 more
Locations
  • Arizona Liver Health Chandler, Arizona, United States
  • Altman Clinical and Translational Research Clinic La Jolla, California, United States
  • Ruane Clinical Research Group Inc. Los Angeles, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
View all 13 locations
View Trial Details

Related conditions